Suppressing miRNA-15a/-16 expression by interleukin-6 enhances drug-resistance in myeloma cells

J Hematol Oncol. 2011 Sep 22:4:37. doi: 10.1186/1756-8722-4-37.

Abstract

The bone marrow microenvironment facilitates the survival, differentiation, and proliferation of myeloma (MM) cells. This study identified that microRNA-15a and -16 expressions tightly correlated with proliferation and drug sensitivity of MM cells. miRNA-15a/-16 expression in MM cells was significantly increased after treatment with cytotoxic agents. The interaction of bone marrow stromal cells (BMSC) with MM cells resulted in decreased miRNA-15a/-16 expression and promoted the survival of the MM cells. Interleukin-6 (IL-6) produced by BMSCs suppressed the expression of miRNA-15a and 16 in a time- and dose- dependent pattern, with the suppression on miRNA-15a being more significant than on miRNA-16. miRNA-15a-transfected MM cells were found to be arrested in G1/S checkpoint, and the transfected MM cells had decreased growth and survival. In conclusion, our data suggest that via suppressing miRNA-15a and -16 expressions, IL-6 secreted by BMSCs promotes drug-resistance in myeloma cells.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Bone Marrow Cells / drug effects*
  • Bone Marrow Cells / metabolism
  • Drug Resistance, Neoplasm
  • Gene Expression Regulation / physiology*
  • Humans
  • Interleukin-6 / genetics
  • Interleukin-6 / metabolism*
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Multiple Myeloma / drug therapy*

Substances

  • Antineoplastic Agents
  • Interleukin-6
  • MicroRNAs